3 Vehicle Lighting Maker, Branded Pharmaceuticals Company and Electrical Goods Maker Stocks With a Strong Future Roadmap: Varroc Engineering, Torrent Pharmaceuticals and Havells India

Headlamp, branded medicine and switchgear stocks let investors follow companies that serve a growing part of the Indian economy. Varroc Engineering, Torrent Pharmaceuticals and Havells India cover a vehicle lighting maker, a branded pharmaceuticals company and an electrical goods maker.

This list covers three headlamp, branded medicine and switchgear stocks with complete current figures: Varroc Engineering, Torrent Pharmaceuticals and Havells India. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Headlamp, Branded Medicine and Switchgear Stocks?

Headlamp, branded medicine and switchgear stocks are listed companies that make headlamps, polymer parts and electronics for vehicles, develop and sell branded medicines for heart, brain and stomach care, and make switches, wires, fans and appliances for homes and industry. Their earnings depend on vehicle output, prescription demand and building activity.

Headlamp, Branded Medicine and Switchgear Stocks at a Glance

On valuation, Havells India trades at a P/E below the industry P/E, while Varroc Engineering and Torrent Pharmaceuticals trade above it, which reflects the growth the market already expects. Readers comparing headlamp, branded medicine and switchgear stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Headlamp, Branded Medicine and Switchgear Stocks Have a Strong Roadmap in India?

Headlamp, branded medicine and switchgear stocks have a strong roadmap in India because rising vehicle production, steady demand for branded medicines and strong housing and power investment keep widening the market for these companies.

• Vehicle lighting. Newer vehicles use advanced lighting.
• Branded medicines. Doctors prescribe trusted chronic care brands.
• Electrical goods. New homes need wiring, fans and appliances.

Why Varroc Engineering Features Among These Headlamp, Branded Medicine and Switchgear Stocks

Among the headlamp, branded medicine and switchgear stocks on this list, Varroc Engineering is a Maharashtra-based automotive component maker with a focus on exterior lighting systems, electrical and electronic parts and polymer products for two-wheeler, passenger car and commercial vehicle makers across the world.

Revenue rose from Rs 5,878 crore in FY22 to Rs 8,917 crore in FY26, a compound annual growth rate of 11.0%. Net profit for FY26 was Rs 230 crore, a net margin of 2.6%.

In the June 2026 quarter, revenue grew 29.9% year on year to Rs 2,640 crore. The company has a return on equity of 14.3%, a debt to equity ratio of 0.52 and a market capitalisation of Rs 12,256 crore. The stock trades at a P/E of 61.2, above the industry P/E of 36.9.

Roadmap: The company is growing its lighting business with advanced LED products and increasing content per vehicle in India and overseas. Orders from vehicle makers, including electric vehicle programmes, give visibility on future volumes.

What to watch: Monitor order wins in lighting and the growth of content per vehicle.

Why Torrent Pharmaceuticals Features Among These Headlamp, Branded Medicine and Switchgear Stocks

Among the vehicle light, prescription drug and fan shares on this list, Torrent Pharmaceuticals is an Ahmedabad-based pharma company that leads in cardiovascular, central nervous system and gastro-intestinal therapies in India, with a growing presence in Brazil, Germany and the United States.

In the June 2026 quarter, revenue grew 56.3% year on year to Rs 4,909 crore, while net profit rose 3.3% to Rs 566 crore. Revenue rose from Rs 8,705 crore in FY22 to Rs 13,886 crore in FY26, a compound annual growth rate of 12.4%.

Net profit grew from Rs 777 crore in FY22 to Rs 2,138 crore in FY26, which works out to a compound annual growth rate of 28.8%. The company has a return on equity of 25.5%, a debt to equity ratio of 1.79 and a market capitalisation of Rs 173,079 crore. The stock trades at a P/E of 80.3, above the industry P/E of 36.0.

Roadmap: The company has strengthened its domestic position through acquisition of established brands and focuses on chronic therapies, where repeat prescriptions support sales. Its overseas markets contribute a steady share of revenue and add geographic balance.

What to watch: Watch the integration of newly acquired brands and the progress of margin improvement in the enlarged business.

Why Havells India Features Among These Headlamp, Branded Medicine and Switchgear Stocks

Among the three companies on this list, Havells India is a leading electrical products company that sells fans, lighting, switchgear, wires and cables, and consumer appliances, along with Lloyd air conditioners.

The company has a return on equity of 17.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 68,928 crore. The stock trades at a P/E of 42.2, below the industry P/E of 44.3.

Revenue rose from Rs 14,099 crore in FY22 to Rs 23,022 crore in FY26, a compound annual growth rate of 13.0%. Net profit grew from Rs 1,196 crore in FY22 to Rs 1,689 crore in FY26, which works out to a compound annual growth rate of 9.0%. In the June 2026 quarter, revenue grew 19.0% year on year to Rs 6,572 crore.

Roadmap: The company sells through a wide dealer network and keeps adding premium products and new categories such as air conditioners and water heaters. Capacity expansion in cables and appliances supports future growth.

What to watch: Check growth in the cables and Lloyd air conditioner businesses.

Varroc Engineering vs Torrent Pharmaceuticals vs Havells India on Key Financials

The table below sets the three headlamp, branded medicine and switchgear stocks side by side on revenue, profit and margin, using reported figures.

Torrent Pharmaceuticals posts the highest return on equity in this group at 25.5%. Havells India combines the largest FY26 revenue at Rs 23,022 crore with the fastest revenue growth, a 13.0% compound annual rate. A useful habit with headlamp, branded medicine and switchgear stocks is to check each new quarterly result against the capacity plans the company described earlier.

The June 2026 quarter, the latest reported, gives a fresh read on momentum:

Key Risks to Check Before Investing in Headlamp, Branded Medicine and Switchgear Stocks

Every theme carries risks that deserve a check before any decision. For these headlamp, branded medicine and switchgear stocks, the main points are: Long-term vehicle light, prescription drug and fan shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

• Production cycles. Vehicle output can vary with demand.
• Pricing pressure. Generic prices can change by market.
• Raw material costs. Ingredient and packaging prices can move margins.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter headlamp, branded medicine and switchgear stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Headlamp, Branded Medicine and Switchgear Stocks

Headlamp, branded medicine and switchgear stocks reward investors who follow demand trends, order books and margins together. Varroc Engineering, Torrent Pharmaceuticals and Havells India each have a clear plan to grow. Based on the 11 November 2026 close, Varroc Engineering trades at Rs 823.05, Torrent Pharmaceuticals at Rs 4,761 and Havells India at Rs 1,184.1. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these headlamp, branded medicine and switchgear stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track headlamp, branded medicine and switchgear stocks, set price alerts and get research-backed stock ideas.

What are headlamp, branded medicine and switchgear stocks?

Ans. Headlamp, branded medicine and switchgear stocks are listed companies that make headlamps, polymer parts and electronics for vehicles, develop and sell branded medicines for heart, brain and stomach care, and make switches, wires, fans and appliances for homes and industry. Their earnings depend on vehicle output, prescription demand and building activity. This list looks at three of them, Varroc Engineering, Torrent Pharmaceuticals and Havells India, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.

Which headlamp, branded medicine and switchgear stocks are covered in this list?

Ans. This list covers Varroc Engineering, Torrent Pharmaceuticals and Havells India. Based on the 11 November 2026 close, Varroc Engineering traded at Rs 823.05, Torrent Pharmaceuticals at Rs 4,761 and Havells India at Rs 1,184.1. Their return on equity ranges from 14.3% to 25.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 11.0% to 13.0%.

Why do headlamp, branded medicine and switchgear stocks have a strong future roadmap in India?

Ans. Headlamp, branded medicine and switchgear stocks have a strong roadmap in India because rising vehicle production, steady demand for branded medicines and strong housing and power investment keep widening the market for these companies. The main drivers are as follows. Vehicle lighting. Newer vehicles use advanced lighting. Branded medicines. Doctors prescribe trusted chronic care brands. Electrical goods. New homes need wiring, fans and appliances. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Varroc Engineering performed financially?

Ans. Revenue rose from Rs 5,878 crore in FY22 to Rs 8,917 crore in FY26, a compound annual growth rate of 11.0%. Net profit for FY26 was Rs 230 crore, a net margin of 2.6%. In the June 2026 quarter, revenue grew 29.9% year on year to Rs 2,640 crore. The company has a return on equity of 14.3%, a debt to equity ratio of 0.52 and a market capitalisation of Rs 12,256 crore. The stock trades at a P/E of 61.2, above the industry P/E of 36.9. Looking ahead, the company is growing its lighting business with advanced LED products and increasing content per vehicle in India and overseas. Orders from vehicle makers, including electric vehicle programmes, give visibility on future volumes.

How has Torrent Pharmaceuticals performed financially?

Ans. Revenue rose from Rs 8,705 crore in FY22 to Rs 13,886 crore in FY26, a compound annual growth rate of 12.4%. Net profit grew from Rs 777 crore in FY22 to Rs 2,138 crore in FY26, which works out to a compound annual growth rate of 28.8%. In the June 2026 quarter, revenue grew 56.3% year on year to Rs 4,909 crore, while net profit rose 3.3% to Rs 566 crore. The company has a return on equity of 25.5%, a debt to equity ratio of 1.79 and a market capitalisation of Rs 173,079 crore. The stock trades at a P/E of 80.3, above the industry P/E of 36.0. Looking ahead, the company has strengthened its domestic position through acquisition of established brands and focuses on chronic therapies, where repeat prescriptions support sales. Its overseas markets contribute a steady share of revenue and add geographic balance.

How has Havells India performed financially?

Ans. Revenue rose from Rs 14,099 crore in FY22 to Rs 23,022 crore in FY26, a compound annual growth rate of 13.0%. Net profit grew from Rs 1,196 crore in FY22 to Rs 1,689 crore in FY26, which works out to a compound annual growth rate of 9.0%. In the June 2026 quarter, revenue grew 19.0% year on year to Rs 6,572 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 68,928 crore. The stock trades at a P/E of 42.2, below the industry P/E of 44.3. Looking ahead, the company sells through a wide dealer network and keeps adding premium products and new categories such as air conditioners and water heaters. Capacity expansion in cables and appliances supports future growth.

What risks should investors check before buying headlamp, branded medicine and switchgear stocks?

Ans. Investors should check a few risks before buying headlamp, branded medicine and switchgear stocks. Production cycles. Vehicle output can vary with demand. Pricing pressure. Generic prices can change by market. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of headlamp, branded medicine and switchgear stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.